Asset / Drug

Pipeline Update

Drug and asset intelligence for Pipeline Update with 12 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 0
Catalysts: 12
Stage: Development stage unavailable

Sponsor company

Merck →

Recent signals

No signals indexed for this entity yet.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts(12)

Topline Data

— Pipeline Update

Monitor advancements in EBV vaccine trials and any emerging data linking EBV prevention to reduced MS incidence.

June 21, 2026 · N/A

Topline Data

— Pipeline Update

Monitor upcoming preclinical and clinical studies evaluating Peptide-1's efficacy and safety in colorectal cancer patients.

June 21, 2026 · N/A

Topline Data

— Pipeline Update

Monitor further preclinical and clinical trials assessing the efficacy and safety of VA-SNEDDS in liver fibrosis.

June 20, 2026 · N/A

Topline Data

— Pipeline Update

Monitor the progress of ongoing clinical trials targeting pediatric hypertension and any FDA approvals for new therapies in this area.

June 20, 2026 · N/A

Topline Data

Avidity Biosciences, Inc. — Pipeline Update

Monitor patient enrollment rates and any updates on regulatory status or outcomes from the Managed Access Program.

June 20, 2026 · N/A

Topline Data

— Pipeline Update

Monitor clinical trial outcomes for NK cell therapies, especially those utilizing novel engineering and combination strategies.

June 19, 2026 · N/A

Topline Data

— Pipeline Update

Watch for the release of findings related to biomarker discovery and their clinical relevance in PH management.

June 19, 2026 · N/A

Topline Data

Moderna — Pipeline Update

Monitor the progress of clinical trials for the HPV16 E7 vaccine and the development of the multivalent mRNA vaccine targeting multiple HPV genotypes.

June 17, 2026 · N/A

Topline Data